US Refinery Reveals Status of Different Companies
Several planned and unplanned production outages at different US refineries has been reported recently, with the list released coming from both official and unofficial sources. HollyFrontier (HFC) revealed on February 28 that first quarter crude prices from its Artesia refinery, while performing maintenance of its hydrotreaters. It is also scheduled to perform a turnaround at more »
2011 Financials Revealed by Hanesbrands
Considered to be a leader in daily branded basic apparel, Hanesbrands Incorporated (HBI) has recently bared its financial performance for the fourth quarter and full year ending December 31, 2011. Net sales for the said fiscal year were at $4.6 billion which represents a 7 percent increase to the previous year. Net income was pegged more »
Cerner Reveals Fourth Quarter and Full Year 2011 Financials
From Kansas City, Missouri, Cerner Corporation (CERN) has given an account of its 2011 fourth quarter and full year financial performance ending December 31, 2011, specifically information on its bookings, revenues, earnings and cash flow. There were $900 million in bookings recorded for the fourth quarter, which appears to be the best performance of the more »
Quarterly Financials of Allergan
Allergan Incorporated (AGN) revealed its earnings for the quarter on Thursday, baring earnings of $1 per share, meeting the consensus estimate of Thomson Reuters. Quarterly performance showed an increase of 7 percent from previous year’s showing for the same period. In a research note given to investors on December 9, 2011, Zacks Investment Research analysts more »
Pharmaceutical Companies Get Okay on Drug
On their third attempt, pharmaceuticals Amylin Pharmaceuticals Incorporated (AMLN) and Alkermes Plc (ALKS) both succeeded in getting government approval for Bydureon, a diabetic drug. The drug was given approval by the Food and Drug Administration for adults with Type 2 diabetes, which was posted on its website. A long-acting form of Byetta, Bydureon is administered more »
Xilinx Lower Profits Surpass Estimates
Xilinx Incorporated (XLNX, a company that manufactures programmable logic devices, bared its third quarter profit that dipped 17 percent due to declining sales on several of its markets. Despite the downturn, however, the company still topped Wall Street estimates pushing its shares up during extended trade on the Nasdaq. Xilinx revealed third quarter net income more »
Lobby Spending Increased By AT&T
A 30+ percent boost in lobbying expenses was made by AT&T Incorporated (T) in pushing a failed campaign to gain US Government approval of its planned purchase of competitor T-Mobile USA Inc. The second biggest wireless company in the US financed its operations by some $20 million last year compared to only $15.5 million in more »
McKesson Bares Third Quarter Financials
Revenues for the third quarter ending December 31, 2011 were disclosed by McKesson Corporation (MCK), which increased by about 10 percent to $31 billion as against revenues of $28 billion last year. Based on GAAP, there was $1.20 per share earnings for the third quarter compared to $0.60 last year. The third quarter GAAP results more »
Private Placement Pricing by Chesapeake Midstream
Private placement amounting to $750 million in senior notes maturing in 2022 has been priced today by Chesapeake Midstream Partners, L.P. (CHKM) The offering has been increased considerably from a previously announced amount of $600 million. There will be a 6.125 percent yearly interest rate with the offering to be opened on January 11, 2012 more »
Alexion Buys Enobia For $1B
In making a strong finish for 2011, Alexion Pharmaceuticals Incorporated (ALXN) bared firm negotiations to purchase Enobia Pharmaceuticals and its foremost hypophosphatasia drug in the staggering amount of about $1.1 billion. Based on the deal, Alexion is giving $610 million in cash upon finalization of the negotiation and an additional $470 million after completion of more »